Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2023

Filter by date:

Select year

Select month

Showing 1262 press releases before 2023

Koselugo (selumetinib) approved in US for paediatric patients with neurofibromatosis type 1 plexiform neurofibromas
13 April 2020
Tagrisso Phase III ADAURA trial will be unblinded early after overwhelming efficacy in the adjuvant treatment of patients with EGFR-mutated lung cancer
10 April 2020
AstraZeneca divestment of Movantik to RedHill Biopharma completed
2 April 2020
Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis
31 March 2020
Brilinta reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
30 March 2020
Imfinzi approved in the US for extensive-stage small cell lung cancer
30 March 2020
Farxiga Phase III DAPA-CKD trial will be stopped early after overwhelming efficacy in patients with chronic kidney disease
30 March 2020
Farxiga reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial
28 March 2020
Lokelma approved in Japan for the treatment of hyperkalaemia
26 March 2020
AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration
25 March 2020

<
1
2
3
126
>

All of our latest press releases and articles are available to explore

Use a maximum of two downloads here

Explore